Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Wujiang Pharmaceutical is a specialized pharmaceutical company based in the Wujiang District of Suzhou, China, primarily focused on the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is a significant manufacturer of psychotropic medications and antihistamines, including widely used agents such as chlorpromazine and promethazine. Following its acquisition by China Grand Pharmaceutical and Healthcare Holdings, the company has integrated into a larger healthcare conglomerate, leveraging its manufacturing expertise to supply both domestic and international markets. Its core business revolves around the large-scale synthesis of small molecule drugs targeting central nervous system disorders and allergic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wu Jiang.